Skip over navigation

News & Events

Newsroom


	Non-invasive brain stimulation shows promise in reducing psychological distress in advanced illness April 8, 2024 - A small clinical trial at The Ottawa Hospital and Bruyère has shown for the first time that repetitive transcranial magnetic stimulation (rTMS) holds promise as a treatment for psychological distress in people with advanced illness.


	The Ottawa Hospital appoints new leader for research and innovation April 2, 2024 - The Ottawa Hospital (TOH) is delighted to announce the appointment of Dr. Rebecca Auer as Executive Vice-President of Research and Innovation at TOH and CEO and Scientific Director of the hospital’s research institute (OHRI).


	Are EVs travelling to injured lungs? March 15, 2024 - Tiny particles called extracellular vesicles (EVs) released by mesenchymal stem cells (MSCs) have shown clear potential to treat several lung diseases in animal models by reducing inflammation. However, there has been debate about where MSC-EVs ...


	Can a blood test predict if MS attacks will come back after stopping treatment? March 15, 2024 - Some people prefer to stop immune-suppressing treatment if their disease has been stable for years, but there’s no way to know whether their symptoms will return.


	MedEd research: survey reveals tips to improve medical learner handover March 15, 2024 - A survey of 29 medical learners suggests that actively involving learners in the handover process between supervisors could provide an excellent learning opportunity and relieve learner anxiety about the process.

See all news items \| See only press releases \| Search for news and experts by disease / specialty

Media contacts

Amelia Buchanan
Senior Communication Specialist
613-297-8315
ambuchanan@ohri.ca

Jennifer Ganton
Director, Communications and Public Relations,
613-614-5253
jganton@ohri.ca